Definitive Contract 75N93022C00026
Award Date
7/1/22
Potential Completion Date
6/30/23
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Lynntech Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,488,107.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Tetracore, Inc., a small business based in Rockville, Maryland. The contract is for the Phase II development of a rapid molecular assay for the point-of-care detection of Treponema pallidum, the causative agent of syphilis. This contract was awarded under the Small Business Innovation...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, has awarded a Small Business Innovation Research (SBIR) Phase I Definitive Contract with a ceiling value of $299,326.00 to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract requires Lynntech to design and develop a novel "3IN1" approach to efficiently collect samples (blood, sputum, urine) in field locations to support surveillance...
This is a federal contract award to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $299,997.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for the development of a Rapid Point-of-Care HIV Viral Load Test, which aligns with NIAID's mission to conduct and...
Tetracore, Inc. was awarded a $299,973 firm fixed price Small Business Innovation Research Phase I contract by the National Institute of Allergy and Infectious Diseases to develop a rapid molecular assay for point-of-care detection of Treponema pallidum. Work will be performed in Potomac, Maryland and involves research to create a new syphilis detection test with a faster turnaround time. As a small business, Tetracore specializes in assays and reagents for infectious disease detection and has...
The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $223,568.00, is for the development of a "Simple, Inexpensive Unit for Removing Cells from Small Amounts of Blood in Resource-Limited Settings." This contract is a Firm Fixed Price...
This is a $2,088,942.54 Cost Plus Fixed Fee contract awarded by the Department of the Army Medical Command to Lynntech Inc., a small business technology development company in College Station, Texas. The contract is for a Phase II Small Business Innovation Research (SBIR) effort to develop a point-of-care test for disease severity and risk stratification. The research is being conducted under SBIR Proposal #H2-0383, with a completion date of January 11, 2025. Lynntech has previously received...
This is a $300,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, titled "CORNAUCOPIA - A METHOD TO DELIVER MULTIPLE BNABS IN THE SAME RNA," is a total small business set-aside with an ultimate completion date of August 14, 2025. Lynntech Inc. has...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute, a civilian agency, to Lynntech Inc., a small business technology development company. The $299,984 firm-fixed-price contract is for research and development in the biomedical field, specifically basic research. The contract was set aside for small businesses. Lynntech has extensive experience conducting contracted research and prototype development for various government...
Lynntech Inc., doing business as Lynntech Inc., has been awarded a $1.5 million firm fixed price SBIR Phase II contract from the National Institutes of Health's National Center for Advancing Translational Sciences to research substrate alternatives for organ-on-a-chip applications. The three-year contract will be performed in College Station, Texas and supports the agency's goal of improving human health through innovative translational sciences. As a total small business set-aside, this award...
This is a $149,986.37 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Lynntech Inc., a small business. The contract is for research and development services related to the SBIR program. Lynntech provides a range of R&D, testing, and evaluation services to federal agencies across defense, health, and energy sectors. The company has received numerous prime and subcontract awards from the Department of Defense, as well as...